Compounds > 2-fluoro-2-deoxyglucose-6-phosphate

2-fluoro-2-deoxyglucose-6-phosphate and Gastrointestinal-Stromal-Tumors

2-fluoro-2-deoxyglucose-6-phosphate has been researched along with Gastrointestinal-Stromal-Tumors* in 1 studies

Other Studies

1 other study(ies) available for 2-fluoro-2-deoxyglucose-6-phosphate and Gastrointestinal-Stromal-Tumors

ArticleYear
Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour.
    The Lancet. Oncology, 2005, Volume: 6, Issue:9

    Topics: Antineoplastic Agents; Benzamides; Diagnostic Errors; Drug Monitoring; Drug Resistance, Neoplasm; Female; Gastrointestinal Stromal Tumors; Glucose-6-Phosphate; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Sequence Deletion

2005